Advertisement
Advertisement

SUPN

SUPN logo

Supernus Pharmaceuticals, Inc.

47.64
USD
Sponsored
+0.88
+1.88%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

47.62

-0.02
-0.05%

Supernus Pharmaceuticals, Inc. Financial Snapshot

Market Cap
2.77B
Beta
0.56
Earnings Per Share (EPS)
-1.92
Price-to-Book (P/B) Ratio
2.64
Operating Margin
14.14%
Total Debt/Equity (D/E)
0.00%
P/E Ratio
22.81
Return on Equity (ROE)
11.13%
Current Ratio
1.96%
Free Cash Flow
66.52M

Earnings Chart

Latest News & Forecasts

Advertisement